Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1998-10-01
2000-07-18
Riley, Jezia
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
435 911, 435 912, 514 44, 536 221, 536 231, 536 243, 536 2431, 536 2433, C12Q 168, C12P 1934, C07H 1900
Patent
active
06090559&
ABSTRACT:
Disclosed are diagnostic techniques for the detection of human prostate cancer. Genetic probes and methods useful in monitoring the progression and diagnosis of prostate cancer are described. The invention relates particularly to probes and methods for evaluating the presence of RNA species that are differentially expressed in prostate cancer compared to normal human prostate or benign prostatic hyperplasia.
REFERENCES:
patent: 4800159 (1989-01-01), Mullis et al.
patent: 5043272 (1991-08-01), Hartley
patent: 5089386 (1992-02-01), Stackebrandt et al.
patent: 5262311 (1993-11-01), Pardee et al.
patent: 5312733 (1994-05-01), MacLeod
patent: 5527884 (1996-06-01), Russell et al.
An et al., "Isolation of genes differentially expressed in prostate cancer cells with metastatic potential by arbitrarily-primed differential analyses (ADA),"Proceedings of the American Association for Cancer Research, 36:82, 1995.
Bova et al., "Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer," Cancer Research, 53:3869-9873, 1993.
Carter and Coffey, "The prostate: an increasing medical problem," The Prostate, 16:39-49, 1990.
Donohue et al., "A Delayed-early gene actviated by fibroblast growth factor-1 encodes a protein related to aldose reductase," The Journal of Biological Chemistry, 269(11):8604-8609, 1994.
Hastbacka et al., "The diastroophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping," Cell, 78(6):1073-1087, 1994.
Isaacs et al., "Molecular biology of prostate cancer," Seminars in Oncology, 21(5):514-521, 1994.
Liang and Pardee, "Differential display of eukaryotic messenger rna by means of the polymerase chain reaction," Science, 257:967-971, 1992.
Liang et al., "Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells," Cancer Research, 52:6966-6968, 1992.
Macoska et al., "Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer," Cancer Research, 54:3824-3830, 1994.
Mok et al., "Molecular cloning of differentially expressed genes in human epithelial ovarian cancer," Gynecologic Oncology, 52:247-252, 1994.
Morton et al., Multivariate analysis of the relationship between survival and the microstage of primary melanoma by clark level and breslow thickness, Cancer, 71(11):3737-3743, 1993.
Morton et al., "Reduction of e-cadherin levels and deletion of the .alpha.-catenin gene in human prostate cancer cells," Cancer Research, 53:3585-3590, 1993.
Partin et al., "Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer," Cancer Research, 53:744-746, 1993.
Sager et al., "Identification by differential display of alpha 6 integrin as a candidate tumor suppressor gene," The FASEB Journal, 7:964-970, 1993.
Slamon et al., "Expression of cellular oncogenes in human malignancies, " Science, 224:256-262, 1984.
Umbas et al., "Expression of the cellular adhesion molecule e-cadherin is reduced or absent in high-grade prostate cancer," Cancer Research, 52:5104-5109, 1992.
Wallis, "The importance of being sulphated," Current Biology, 5(3):225-227, 1995.
Watson and Fleming, "Isolation of differentially expressed sequence tags from human breast cancer," Cancer Research, 54:4598-4602, Sep. 1994.
Welsh et al., "Arbitrarily primed pcr fingerprinting of RNA," Nucleic Acids Research, 20(19):4965-4970, 1992.
Wong et al., "Identification of differentially expressed RNA in human ovarian carcinoma cells by arbitrarily primed PCR fingerprinting of total RNAs," International Journal of Oncology, 3:13-17, 1993.
An et al., "Sensitive, nonradioactive differential display method using chemiluminescent detection," Biotechniques, 20(3):342, 344 and 346, 1996.
Blok et al., "Isolation of cDNAs that are differentially expressed between androgen-dependent and androgen-independent prostate carcinoma cells using differential display PCR," Prostate, 26(4):231-224, 1995.
International Search Report dated Sep. 12, 1997 (PCT/US97/05335)(UROC:007).
Robson et al., "Isolation of prostatic androgen regulated genes using the differential display technique," Proc. Am. Assoc. Cancer Res. Ann. Meet., 36:266, 1995.
Cherry et al., "The internally located telomeric sequences in the germ-line chromosomes of tetrahymena are at the ends of transposon-like elements," Cell, 43:747-758, 1985.
Hirt et al., "Localization and fine structure of a vaccinia virus gene encoding an envelope antigen," Journal of Virology, 58:757-764, 1986.
Hunter et al., "A laminin-like adhesive protein concentrated in the synaptic cleft of the neuromuscular junction," Nature, 338:229-233, 1989.
Iris et al., "Dense Alu clustering and a potential new member of the NF B family within a 90 kilobase HLA class III segment," Nature Genetics, 3:137-145, 1993.
Nakada et al., "Influenza C virus hemagglutinin: Comparison with influenza A and B virus hemagglutinins," Journal of Virology, 50:118-124, 1994.
Sargent et al., "Nucleotide sequence of cloned rat serum albumin messenger RNA," Proc. Natl. Acad. Sci., USA, 78:243-246, 1981.
Sukhatme et al., "A sinz finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization," Cell, 53:37-43, 1988.
Wright et al., "Expression of a zinc finger gene in HTLV-I and HTLV-II transformed cells," Science, 248-588-591, 1990.
Russell David W.
Thigpen Anice E.
Riley Jezia
Urocor Inc.
LandOfFree
Biomarkers for the detection of prostate cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biomarkers for the detection of prostate cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomarkers for the detection of prostate cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2034975